Pharmaceuticals news FT.com

Biotech behind Eli Lilly obesity pill aims for new standard of care

Chugai Pharmaceutical looks to combine orforglipron with its drug to tackle muscle wasting

Jun 8, 2025 - 05:45
 0
Biotech behind Eli Lilly obesity pill aims for new standard of care
Chugai Pharmaceutical looks to combine orforglipron with its drug to tackle muscle wasting
Read More

Tags:

Previous Article

The Hidden DNA Repair System That Could Transform Cancer Treatment

Next Article

How a gas deal helped save Equinor’s $5bn New York wind farm

Related Posts

Sanofi to buy US blood disorder drugmaker for up to $9.5bn

Sanofi to buy US blood disorder drugmaker for up to $9.5bn

Jun 2, 2025  0

Citi charts crimes

Citi charts crimes

Jun 6, 2025  0

Swiss drugmaker Novartis to invest $23bn in US manufacturing and R&D

Swiss drugmaker Novartis to invest $23bn in US manufact...

May 12, 2025  0